Vertex Pharmaceuticals, Inc. (VRTX)

CAPS Rating:

The Company is in the business of discovering, developing and commercializing small molecule drugs for the treatment of serious diseases.

View Ticker Page (VRTX)

Results 11 - 20 of 115 : 1 2 3 4 5 Next »

Recs

1

Avatar NovaMechanika (62.42) Submitted: 3/19/08 10:18 PM : Start Price: $15.55 VRTX Score: 73.70

Super duper biopharm pick with a super drug that means super profits after all the red tape clears. Scoop it up, then eat a ham sandwich as a celebration.

Report this Post Replies: 0 | Reply | Permalink

Recs

1

Avatar Ghostgames (51.57) Submitted: 7/10/07 7:49 PM : Start Price: $28.51 VRTX Score: 8.78

Vertex Pharmaceuticals uses computer modeling to help them research drugs. They start with a problem (a disease) and build molecules to solve that problem. This greatly shortens their time to get drugs to market (compared with most of their competito...

Report this Post Replies: 0 | Reply | Permalink

Recs

1

Avatar Ganndalf (< 20) Submitted: 2/13/07 9:40 PM : Start Price: $31.36 VRTX Score: -3.29

Let me be perfectly honest...

I have been rummaging in Databasebob's very full closet of stocks, and all the way down at the bottom of the heap way in the back I dug up this little gem. I hope he doesn't miind if I just borrow it for a little while...

Report this Post Replies: 1 | Reply | Permalink

Recs

1

Avatar NuvoRiche (82.19) Submitted: 4/20/07 11:32 PM : Start Price: $35.23 VRTX Score: -13.10

Remember Protease Inhibitors, the drug class that turned HIV from a death sentence to a survivable chronic illness? Well they're back, this time Vertex is developing one that shows great promise for the treatment of Hepatitis C virus (HCV). CDC rep...

Report this Post Replies: 0 | Reply | Permalink

Recs

1

Avatar TMFBreakerJava (99.33) Submitted: 5/19/06 6:16 AM : Start Price: $29.30 VRTX Score: -9.84

This gem has been beaten up in the general biotech wreck of late and I am happy to jump in at this price. It has great prospects in its VX-950 drug candidate for HEP-C, as well as an interesting prospect in for the treatment of Rheumatoid Arthritis....

Report this Post Replies: 0 | Reply | Permalink

Recs

1

Avatar conliskjr (< 20) Submitted: 8/24/06 10:56 PM : Start Price: $33.34 VRTX Score: -18.83

I liked it at 8, 16, 25 ... why not now! Really, it seems to have the firepower to keep this up for the long-term.

Report this Post Replies: 0 | Reply | Permalink

Recs

1

Avatar PoorLibrarian (33.05) Submitted: 8/24/06 9:17 PM : Start Price: $33.34 VRTX Score: -18.83

When VX-950 gets approval, the sky's the limit for the (expected) first-to-market cure for Hepatitis C -- a market of up to $10 billion, and a company with a market cap of $3.5 billion? Good math, even if they didn't have a strong pipeline of other ...

Report this Post Replies: 0 | Reply | Permalink